Lexicon Pharmaceuticals, Inc.
LXRX
$2.32
-$0.02-0.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -31.78M | -1.04M | -15.53M | -12.77M | 3.25M |
| Total Depreciation and Amortization | 102.00K | 110.00K | 118.00K | 151.00K | 176.00K |
| Total Amortization of Deferred Charges | 532.00K | 681.00K | 495.00K | 402.00K | 402.00K |
| Total Other Non-Cash Items | 7.44M | 1.94M | 2.23M | 2.69M | 1.96M |
| Change in Net Operating Assets | 14.51M | -16.41M | -4.55M | -14.31M | 11.20M |
| Cash from Operations | -9.19M | -14.73M | -17.23M | -23.83M | 16.99M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -16.46M | -70.26M | 4.83M | 52.13M | 15.48M |
| Cash from Investing | -16.46M | -70.26M | 4.83M | 52.13M | 15.48M |
| Total Debt Issued | 55.00M | -- | -- | -- | -- |
| Total Debt Repaid | -54.26M | -5.00M | -3.00M | 0.00 | -45.00M |
| Issuance of Common Stock | 1.02M | 70.05M | 73.00K | -- | -- |
| Repurchase of Common Stock | 0.00 | -2.84M | 0.00 | 0.00 | 0.00 |
| Issuance of Preferred Stock | 0.00 | 26.55M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.27M | -- | -- | -- | -- |
| Cash from Financing | -512.00K | 88.76M | -2.93M | 0.00 | -45.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -26.17M | 3.76M | -15.33M | 28.29M | -12.52M |